233 related articles for article (PubMed ID: 31853898)
1. Neurosurgical treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex: a series of 44 surgical procedures in 31 patients.
Giordano F; Moscheo C; Lenge M; Biagiotti R; Mari F; Sardi I; Buccoliero AM; Mongardi L; Aronica E; Guerrini R; Genitori L
Childs Nerv Syst; 2020 May; 36(5):951-960. PubMed ID: 31853898
[TBL] [Abstract][Full Text] [Related]
2. A management strategy for intraventricular subependymal giant cell astrocytomas in tuberous sclerosis complex.
Harter DH; Bassani L; Rodgers SD; Roth J; Devinsky O; Carlson C; Wisoff JH; Weiner HL
J Neurosurg Pediatr; 2014 Jan; 13(1):21-8. PubMed ID: 24180681
[TBL] [Abstract][Full Text] [Related]
3. Surgery for subependymal giant cell astrocytomas in children with tuberous sclerosis complex.
Fohlen M; Ferrand-Sorbets S; Delalande O; Dorfmüller G
Childs Nerv Syst; 2018 Aug; 34(8):1511-1519. PubMed ID: 29766265
[TBL] [Abstract][Full Text] [Related]
4. Subependymal giant-cell astrocytoma: A surgical review in the modern era of mTOR inhibitors.
Danassegarane G; Tinois J; Sahler Y; Aouaissia S; Riffaud L
Neurochirurgie; 2022 Dec; 68(6):627-636. PubMed ID: 35907444
[TBL] [Abstract][Full Text] [Related]
5. The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
Weidman DR; Palasamudram S; Zak M; Whitney R; McCoy B; Bouffet E; Taylor M; Shroff M; Bartels U
J Neurooncol; 2020 May; 147(3):731-736. PubMed ID: 32285309
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients.
Kotulska K; Borkowska J; Roszkowski M; Mandera M; Daszkiewicz P; Drabik K; Jurkiewicz E; Larysz-Brysz M; Nowak K; Grajkowska W; Domańska-Pakieła D; Jóźwiak S
Pediatr Neurol; 2014 Apr; 50(4):307-12. PubMed ID: 24507694
[TBL] [Abstract][Full Text] [Related]
7. Isolated subependymal giant cell astrocytoma (SEGA) in the absence of clinical tuberous sclerosis: two case reports and literature review.
Cobourn KD; Chesney KM; Mueller K; Fayed I; Tsering D; Keating RF
Childs Nerv Syst; 2024 Jan; 40(1):73-78. PubMed ID: 37658938
[TBL] [Abstract][Full Text] [Related]
8. Unique findings of subependymal giant cell astrocytoma within cortical tubers in patients with tuberous sclerosis complex: a histopathological evaluation.
Katz JS; Frankel H; Ma T; Zagzag D; Liechty B; Zeev BB; Tzadok M; Devinsky O; Weiner HL; Roth J
Childs Nerv Syst; 2017 Apr; 33(4):601-607. PubMed ID: 28074282
[TBL] [Abstract][Full Text] [Related]
9. The outcome of surgical management of subependymal giant cell astrocytoma in tuberous sclerosis complex.
Amin S; Carter M; Edwards RJ; Pople I; Aquilina K; Merrifield J; Osborne JP; O'Callaghan FJ
Eur J Paediatr Neurol; 2013 Jan; 17(1):36-44. PubMed ID: 23183057
[TBL] [Abstract][Full Text] [Related]
10. [Hemorrhagic Onset of Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis:A Case Report and Review of Literature].
Adachi M; Nakamura M; Shinozaki N; Miyazaki T
No Shinkei Geka; 2017 May; 45(5):397-404. PubMed ID: 28490681
[TBL] [Abstract][Full Text] [Related]
11. Dose-level response rates of mTor inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
Weidman DR; Pole JD; Bouffet E; Taylor MD; Bartels U
Pediatr Blood Cancer; 2015 Oct; 62(10):1754-60. PubMed ID: 25929843
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging diagnosis of subependymal giant cell astrocytomas in follow-up of children with tuberous sclerosis complex: should we always use contrast enhancement?
Gaillard AL; Crombé A; Jecko V; Bessou P; Havez M; Pédespan JM; Van Gils J; Chateil JF
Pediatr Radiol; 2020 Sep; 50(10):1397-1408. PubMed ID: 32671416
[TBL] [Abstract][Full Text] [Related]
13. A Comparison of Clinical Outcomes for Subependymal Giant Cell Astrocytomas Treated with Laser Interstitial Thermal Therapy, Open Surgical Resection, and mTOR Inhibitors.
Boop S; Bonda D; Randle S; Leary S; Vitanza N; Crotty E; Novotny E; Friedman S; Ellenbogen RG; Durfy S; Goldstein H; Ojemann JG; Hauptman JS
Pediatr Neurosurg; 2023; 58(3):150-159. PubMed ID: 37232001
[TBL] [Abstract][Full Text] [Related]
14. [Subependymal Giant Cell Astrocytoma with Tuberous Sclerosis Complex(TSC-SEGA)].
Ichikawa T; Niida Y
No Shinkei Geka; 2022 Jan; 50(1):111-121. PubMed ID: 35169091
[TBL] [Abstract][Full Text] [Related]
15. Subependymal giant cell tumors in tuberous sclerosis complex.
Goh S; Butler W; Thiele EA
Neurology; 2004 Oct; 63(8):1457-61. PubMed ID: 15505165
[TBL] [Abstract][Full Text] [Related]
16. Presurgical Administration of mTOR Inhibitors in Patients with Large Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis Complex.
Jiang T; Du J; Raynald ; Wang J; Li C
World Neurosurg; 2017 Nov; 107():1053.e1-1053.e6. PubMed ID: 28866062
[TBL] [Abstract][Full Text] [Related]
17. Experience using mTOR inhibitors for subependymal giant cell astrocytoma in tuberous sclerosis complex at a single facility.
Tomoto K; Fujimoto A; Inenaga C; Okanishi T; Imai S; Ogai M; Fukunaga A; Nakamura H; Sato K; Obana A; Masui T; Arai Y; Enoki H
BMC Neurol; 2021 Mar; 21(1):139. PubMed ID: 33784976
[TBL] [Abstract][Full Text] [Related]
18. Subependymal giant-cell astrocytomas in pediatric tuberous sclerosis disease: when should we operate?
de Ribaupierre S; Dorfmüller G; Bulteau C; Fohlen M; Pinard JM; Chiron C; Delalande O
Neurosurgery; 2007 Jan; 60(1):83-89; discussion 89-90. PubMed ID: 17228255
[TBL] [Abstract][Full Text] [Related]
19. The cystic growth of a subependymal giant-cell astrocytoma with tuberous sclerosis.
Sugita Y; Taguchi A; Miyagi J; Yuge T; Tomita T; Shigemori M; Morimatsu M
Kurume Med J; 1992; 39(2):123-8. PubMed ID: 1405432
[TBL] [Abstract][Full Text] [Related]
20. Acute Management of Symptomatic Subependymal Giant Cell Astrocytoma With Everolimus.
Arroyo MS; Krueger DA; Broomall E; Stevenson CB; Franz DN
Pediatr Neurol; 2017 Jul; 72():81-85. PubMed ID: 28511812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
